ESR1 and breast cancer: A burgeoning literature supports the ability of estrogens to signal to multiple cell types in the microenvironments of ER+ breast cancers, which would include not only tumor cells, but also CAFs and immune populations, supported by the widespread distribution of the various estrogen receptors (Figure 1).